文献速递重症综合管理与镇静镇痛

腹腔脓毒症中的内皮糖萼脱落:一项可行性研究

ENDOTHELIAL GLYCOCALYX SHEDDING IN INTRA-ABDOMINAL SEPSIS: A FEASIBILITY STUDY.
PubMed 文献 · Shock · 2023-01-10
一句话结论腹腔脓毒症患者循环和组织内皮糖萼标志物(HA、SDC-1)与术后SOFA评分正相关,组织SDC-1在各时间点均与SOFA显著相关(R=0.69,P<0.0001),但需更大样本评估预测价值。

这项前瞻性、观察性、单中心可行性研究纳入15例成人腹腔脓毒症患者,在手术时及术后24-48小时采集血液和切除组织(病理标本与未受累腹膜),用CD138染色和ELISA分别定量组织和血浆中的HA与SDC-1。结果:循环EGL标志物(HA、SDC-1)升高与术后SOFA评分正相关、与24小时复苏液量弱相关;切除病理组织的SDC-1在所有时间点与SOFA评分显著相关(R=0.69,P<0.0001),与24小时复苏液量正相关(R=0.41,P=0.15)。组织和循环HA、SDC-1在高SOFA评分(SOFA>6)时正相关。作者认为该研究证明了手术室获取组织和血浆的可行性,但需更大研究评估这些EGL标志物的预测价值。

要点

  • 15例成人腹腔脓毒症患者中,切除病理组织的SDC-1在所有时间点与SOFA评分显著相关(R=0.69,P<0.0001)。
  • 组织SDC-1与24小时复苏液量正相关(R=0.41,P=0.15,t=24小时)。
  • 循环EGL标志物(HA、SDC-1)升高与术后SOFA评分正相关,与24小时复苏液量弱相关。
  • 组织和循环HA、SDC-1在SOFA>6时正相关,作者认为可作为术后24小时内复苏需求的指标。
  • 作者认为该研究证明了手术室获取组织和血浆的可行性,但需更大研究评估EGL标志物的预测价值。

适用人群与场景

  • 成人腹腔脓毒症患者(N=15),在手术时及术后24-48小时采集血液和切除组织(病理标本和未受累腹膜)。

研究设计与关键结果

  • 研究类型:前瞻性、观察性、单中心可行性研究;样本量N=15例成人腹腔脓毒症患者。
  • 循环EGL标志物(HA、SDC-1)升高与术后SOFA评分正相关,与24小时复苏液量弱相关。
  • 切除病理组织的SDC-1在所有时间点与SOFA评分显著相关(R=0.69,P<0.0001),与24小时复苏液量正相关(R=0.41,P=0.15,t=24小时)。
  • 组织和循环HA、SDC-1在SOFA>6时正相关。
  • 作者认为组织和循环EGL标志物可作为术后24小时内复苏需求的指标。

证据类型、等级与局限

  • 证据类型:前瞻性、观察性、单中心可行性研究。
  • 局限:原文报告需更大研究评估这些EGL标志物对腹腔脓毒症患者的预测价值。

对床旁实践的改变

  • 作者认为,组织和循环EGL标志物在较高SOFA评分(SOFA>6)时正相关,可作为术后24小时内复苏需求的指标。
  • 作者认为该研究证明了在手术室获取组织和血浆的可行性,但需更大研究评估这些EGL标志物的预测价值。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Background: The endothelial glycocalyx layer (EGL) is a complex meshwork of glycosaminoglycans and proteoglycans that protect the vascular endothelium. Cleavage or shedding of EGL-specific biomarkers, such as hyaluronic acid (HA) and syndecan-1 (SDC-1, CD138) in plasma, have been shown to be associated with poor clinical outcomes. However, it is unclear whether levels of circulating EGL biomarkers are representative of the EGL injury within the tissues. The objective of the present feasibility study was to describe a pathway for plasma and tissue procurement to quantify EGL components in a cohort of surgical patients with intra-abdominal sepsis. We sought to compare differences between tissue and plasma EGL biomarkers and to determine whether EGL shedding within the circulation and/or tissues correlated with clinical outcomes. Methods: This was a prospective, observational, single-center feasibility study of adult patients (N = 15) with intra-abdominal sepsis, conducted under an approved institutional review boards. Blood and resected tissue (pathologic specimen and unaffected peritoneum) samples were collected from consented subjects at the time of operation and 24-48 hours after surgery. Endothelial glycocalyx layer biomarkers (i.e., HA and SDC-1) were quantified in both tissue and plasma samples using a CD138 stain and ELISA kit, respectively. Pairwise comparisons were made between plasma and tissue levels. In addition, we tested the relationships between measured EGL biomarkers and clinical status and patient outcomes. Results: Fifteen patients with intra-abdominal sepsis were enrolled in the study. Elevations in EGL-specific circulating biomarkers (HA, SDC-1) were positively correlated with postoperative SOFA scores and weakly associated with resuscitative volumes at 24 hours. Syndecan-1 levels from resected pathologic tissue significantly correlated with SOFA scores at all time points ( R = 0.69 and P < 0.0001) and positively correlated with resuscitation volumes at 24 hours ( R = 0.41 and P = 0.15 for t = 24 hours). Tissue and circulating HA and SDC-1 positively correlated with SOFA >6. Conclusions: Elevations in both circulating and tissue EGL biomarkers were positively correlated with postoperative SOFA scores at 24 hours, with resected pathologic tissue EGL levels displaying significant correlations with SOFA scores at all time points. Tissue and circulating EGL biomarkers were positively correlated at higher SOFA scores (SOFA > 6) and could be used as indicators of resuscitative needs within 24 hours of surgery. The present study demonstrates the feasibility of tissue and plasma procurement in the operating room, although larger studies are needed to evaluate the predictive value of these EGL biomarkers for patients with intra-abdominal sepsis.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Carmichael SP, Appelbaum RD, Renaldo A, et al. ENDOTHELIAL GLYCOCALYX SHEDDING IN INTRA-ABDOMINAL SEPSIS: A FEASIBILITY STUDY. Shock. 2023. PMID: 36625488. doi:10.1097/SHK.0000000000002079

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。